• Nebivolol hydrochloride Research Workflows

  2026-08-30

  Nebivolol hydrochloride enables precise β1-receptor inhibition for cardiovascular pharmacology research, while its negative result in a sensitized yeast mTOR assay helps define experimental boundaries. This guide pairs receptor-signaling workflows with practical preparation, controls, and troubleshooting strategies.

• Tianhuang Formula, RAGE/POMC, and Metabolic Control

  2026-08-29

  A 2026 pre-proof study identifies RAGE as a central nervous system target of berberine, a major component of Tianhuang Formula, and connects RAGE/POMC signaling with hypothalamic neuronal apoptosis, autophagy, and glucolipid metabolism. Its integrated computational, cellular, and mouse-model design provides a mechanistic framework for studying neuronal homeostasis in metabolic disease, while leaving human translation and broader neurodegenerative applications unresolved.

• Bortezomib (PS-341) Assay Workflows

  2026-08-29

  Use Bortezomib (PS-341) as a reversible 20S proteasome perturbation to connect protein turnover with apoptosis, viability loss, and transcription-linked phenotypes. This workflow-oriented guide covers concentration planning, Pol II-focused assay design, translational cancer models, and practical troubleshooting.

• Balsalazide: Evidence for a 5-ASA Prodrug in UC

  2026-08-28

  The 2009 review by Wiggins and Rajapakse evaluated balsalazide as a colon-targeted 5-aminosalicylate prodrug that is activated by bacterial azoreduction. Its synthesis of clinical evidence suggests effective and rapid remission induction in mild-to-moderate active ulcerative colitis, with tolerability comparable to other oral 5-ASA agents.

• PAD4-IN-2 TFA: Tumor-Targeted NET Workflows

  2026-08-28

  PAD4-IN-2 TFA, also known as Compound 5i TFA, combines PAD4 inhibition with meta-phenylboronic acid-mediated tumor targeting. This guide translates its reported effects on H3cit, NET formation, metastasis, and the tumor immune microenvironment into practical assay workflows and troubleshooting strategies.

• Reelin–SFK Signaling in Ketamine Response

  2026-08-27

  The reference study identifies intact Reelin–Apoer2–Src family kinase signaling as a permissive requirement for ketamine-induced hippocampal plasticity and antidepressant-like behavioral effects in mice. Its genetic and pharmacological experiments suggest that impaired baseline NMDA receptor function, rather than an altered acute Reelin response to ketamine, may contribute to treatment nonresponsiveness.

• Cell Tumbling and Stem Cell Mechanotransduction

  2026-08-27

  Ayushman et al. identify cell tumbling as a rapid, three-dimensional whole-cell movement that deforms sliding hydrogels and enhances mesenchymal stem cell differentiation. Their results connect hydrogel mechanics, cytoskeletal and nuclear activity, and reduced chromatin accessibility, providing a mechanistic framework for studying fast niche remodeling in 3D culture.

• Mubritinib (TAK 165) Complex I Workflows

  2026-08-26

  Mubritinib (TAK 165) enables mechanism-led studies of mitochondrial complex I inhibition in chemotherapy-resistant AML and KSHV-positive PEL models. This guide translates NAD+/NADH biology into practical dosing, assay-design, troubleshooting, and interpretation strategies while placing HER2 findings in their proper experimental context.

• Chemistry of Silybin: Structure, Derivatives, and Assays

  2026-08-26

  The Křen et al. review established a chemistry-centered framework for understanding silybin, the principal flavonolignan of milk thistle extract. Its most important advances were the assignment of the absolute configurations of silybin A and B, improved separation strategies, and systematic coverage of semisynthetic and chemo-enzymatic derivatives that can address solubility and biological-activity questions.

• PPARγ Activation in DSS-Induced IBD

  2026-08-25

  The reference study shows that PPARγ activation attenuates DSS-induced inflammatory bowel disease by shifting macrophage polarization away from an M1-like inflammatory state toward an M2-like reparative state. Its combination of RAW264.7-cell experiments and a murine model connects macrophage phenotype, STAT-1/STAT-6 signaling, intestinal barrier integrity, and clinical disease measures in one mechanistic framework.

• Gamithromycin PK/PD in Bovine Respiratory Disease

  2026-08-25

  The reference study connected gamithromycin exposure in plasma and pulmonary epithelial lining fluid with treatment outcome in feedlot cattle with naturally occurring bovine respiratory disease. Its effect-compartment modeling approach shows why site-of-infection exposure and pathogen-specific MIC values can provide more clinically informative PK/PD measures than plasma data alone.

• Nuclear cGAS Restricts L1 Retrotransposition

  2026-08-24

  This Nature Communications study identifies a nuclear genome-protection function for cGAS: it promotes TRIM41-dependent ubiquitination and degradation of L1 ORF2p, thereby limiting LINE-1 retrotransposition. The work connects DNA damage signaling, protein quality control, senescence, and cancer-associated cGAS mutations through a CHK2–cGAS–TRIM41–ORF2p regulatory axis.

• Losartan Workflows for AT1 Signaling

  2026-08-23

  Losartan provides a controllable way to dissect AT1 receptor signaling across vascular smooth muscle, blood-pressure, and podocyte models. This workflow-focused guide connects concentration planning with receptor, signaling, extracellular-matrix, and functional readouts while highlighting the limits of pharmacological interpretation.

• GI 254023X: Designing Better ADAM10 Assays

  2026-08-22

  Explore how GI 254023X, a selective ADAM10 inhibitor, can be used to connect target engagement with substrate cleavage and cellular function. This article applies lessons from quantitative BACE research to build more discriminating ADAM10 experiments while separating established evidence from translational hypotheses.

• CFDA-SE Workflows for Cell Proliferation Tracking

  2026-08-21

  CFDA-SE converts intracellular esterase activity into a durable fluorescence signal that can reveal successive cell divisions by flow cytometry. This guide connects practical labeling workflows with lymphocyte, fibroblast, NK-cell, bacterial, migration, and surfaceome studies while emphasizing controls that prevent misleading proliferation profiles.

448 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page